APA (7th ed.) Citation

F, H., PL, L., H, C., R, C., A, S., & B, M. (2019). Real-World Visual And Clinical Outcomes For Patients With Neovascular Age-Related Macular Degeneration Treated With Intravitreal Ranibizumab: An 8-Year Observational Cohort (AMD8). Dove Medical Press.

Chicago Style (17th ed.) Citation

F, Horner, Lip PL, Clark H, Chavan R, Sarmad A, and Mushtaq B. Real-World Visual And Clinical Outcomes For Patients With Neovascular Age-Related Macular Degeneration Treated With Intravitreal Ranibizumab: An 8-Year Observational Cohort (AMD8). Dove Medical Press, 2019.

MLA (8th ed.) Citation

F, Horner, et al. Real-World Visual And Clinical Outcomes For Patients With Neovascular Age-Related Macular Degeneration Treated With Intravitreal Ranibizumab: An 8-Year Observational Cohort (AMD8). Dove Medical Press, 2019.